Saroglitazar
Saroglitazar (Lipaglyn) is a dual PPAR agonist with high potency, exhibiting EC50 values of 0.65 pM for PPARα and 3 nM for PPARγ. It is utilized in research for studying metabolic disorders, including dyslipidemia and type 2 diabetes, in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
495399-09-2
Product Name Alternative
Lipaglyn, PPARα, PPARγ, Saroglitazar
Field of Research
Metabolism Research, Molecular Biology, Pharmacology & Drug Discovery
Purity
98.49% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.55 mM) ; DMSO:22.5 mg/mL (51.19 mM)
Smiles
CCO[C@@H] (Cc1ccc (OCCn2c (C) ccc2-c2ccc (SC) cc2) cc1) C (O) =O
Molecular Formula
C25H29NO4S
Molecular Weight
439.57
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
H8945 96 Tests
Tripartite motif-containing protein 66 (TRIM66) Mouse ELISA Kit
Sign In for Pricing
View Details MBS6497405-01 0.1 mL
RBBP7, NT (Nucleosome-remodeling Factor Subunit RBAP46, Histone Acetyltransferase Type B Subunit 2, Retinoblastoma-binding Protein p46, Retinoblastoma-binding Protein 7, RBBP-7, Histone-binding Protein RBBP7, RBAP46) (MaxLight 490)
Sign In for Pricing
View Details